Sign up to save your podcasts
Or
Share First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.9
5252 ratings
Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer.
CME information and select publications here.
More shows like Oncology Today with Dr Neil Love
View all
Gastrointestinal Cancer Update
17 Listeners
Lung Cancer Update
32 Listeners
Prostate Cancer Update
15 Listeners
Breast Cancer Update
62 Listeners
Gynecologic Oncology Update
12 Listeners
Hematologic Oncology Update
73 Listeners
Dermatologic Oncology Update
0 Listeners
NEJM This Week
314 Listeners
Journal of Clinical Oncology (JCO) Podcast
39 Listeners
Research To Practice | Oncology Videos
110 Listeners
JAMA Clinical Reviews
478 Listeners
ASCO Daily News
55 Listeners
Core IM | Internal Medicine Podcast
1,085 Listeners
The ONS Podcast
196 Listeners
ASCO Guidelines
44 Listeners
OncLive® On Air
21 Listeners
The Clinical Problem Solvers
512 Listeners
Two Onc Docs
165 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
37 Listeners